We indeed observed that low-dose Lipo-MP-LPS was not able to induce the activation of T-cell responses in periphery and thus tumor infiltration by CD4/CD8 T-cells, which can be related to its lack of efficacy to fully differentiate TAMs toward an M1 phenotype. The gene discussed is CD4; the disease is neoplasm.